Table 2 Summary of IBR mean values of different biomarkers in each treatment of glucose and control. Data is represented in mean ± SE, p value ≤ 0.05.
Biomarkers | Treatment groups | |||||
|---|---|---|---|---|---|---|
T0 (control) | T1 (0.1%) | T2 (0.2%) | T3 (0.3%) | T4 (0.4%) | ||
Serum biomarkers | Cortisol (ng mL−1) | 7.79 ± 0.14 | 3.17 ± 0.04 | 00.00 | 0.29 ± 0.002 | 0.27 ± 0.001 |
GPT(IU L−1) | 8.1 ± 0.07 | 2.3 ± 0.02 | 0.03 ± 0.002 | 0.17 ± 0.005 | 00.00 | |
Triglyceride(mg dL−1) | 6.88 ± 0.04 | 2.03 ± 0.01 | 00.00 | 0.01 ± 0.001 | 0.02 ± 0.001 | |
Creatinine(mg dL−1) | 7.54 ± 0.02 | 1.72 ± 0.03 | 00.00 | 0.02 ± 0.003 | 0.1 ± 0.002 | |
Glucose(mg dL−1) | 4.8 ± 0.03 | 1.76 ± 0.01 | 00.00 | 0.08 ± 0.004 | 3.14 ± 0.08 | |
Oxidative stress biomarkers | SOD liver (U mg protein−1) | 8.63 ± 0.15 | 4.44 ± 0.05 | 00.00 | 1.44 ± 0.05 | 2.04 ± 0.02 |
SOD gill (U mg protein−1) | 4.82 ± 0.08 | 2.13 ± 0.03 | 00.00 | 0.01 ± 0.001 | 0.34 ± 0.007 | |
CAT liver (mmole mg protein−1 min−1) | 4.8 ± 0.05 | 1.76 ± 0.08 | 00.00 | 0.08 ± 0.002 | 3.14 ± 0.05 | |
CAT gill (mmole mg protein−1 min−1) | 7.8 ± 0. 11 | 1.77 ± 0.02 | 00.00 | 0.23 ± 0.001 | 2.37 ± 0.03 | |
Metabolizing biomarkers | LDH liver (micromoles mg protein−1 min−1) | 7.79 ± 0.10 | 2.14 ± 0.07 | 00.00 | 0.06 ± 0.003 | 0.42 ± 0.005 |
LDH muscle (micromoles mg protein−1 min−1) | 7.08 ± 0.18 | 2.25 ± 0.05 | 00.00 | 0.02 ± 0.001 | 0.07 ± 0.003 | |
MDH liver (micromoles mg protein−1 min−1) | 7.11 ± 0.21 | 2.35 ± 0.04 | 00.00 | 0.04 ± 0.003 | 0.1 ± 0.002 | |
MDH muscle (micromoles mg protein−1 min−1) | 6.59 ± 0.26 | 2.48 ± 0.09 | 00.00 | 0.05 ± 0.002 | 0.76 ± 0.008 | |
G-6 phosphatase (nanomoles) | 7.71 ± 0.12 | 1.76 ± 0.09 | 0.02 ± 0.001 | 00.00 | 0.21 ± 0.001 | |
